National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings, 1445-1446 [06-143]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 5 / Monday, January 9, 2006 / Notices
Neurological Disorders and Stroke, National
Institutes of Health, 6001 Executive Blvd.,
Suite 2137, MSC 9527, Bethesda, MD 20892–
9527. (301) 496–1779.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: December 29, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–141 Filed 1–6–06; 8:45am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
cprice-sewell on PROD1PC66 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Neurological
Disorders and Stroke Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contact proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contact proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: February 9–10, 2006.
Open: February 9, 2006, 10:30 a.m. and
4:30 p.m.
Agenda: Report by the Director, NINDS;
Report by the Director, Division of
Extramural Research; Overview of the NINDS
Intramural Program; scientific presentation,
VerDate Aug<31>2005
15:31 Jan 06, 2006
Jkt 208001
and other administration and program
developments.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: February 9, 2006, 4:30 p.m. to 5
p.m.
Agenda: To review and evaluate the
Division of Intramural Research Board of
Scientific Counselors’ reports.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: February 10, 2006, 8 a.m. to 11:30
a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Robert Finkelstein, PhD,
Associate Director for Extramural Research,
National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite
3309, MSC 9531, Bethesda, MD 20892. (301)
496–9248.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
into the building by non-government
employees. Persons without a government
I.D. will need to show a photo I.D. and signin at the security desk upon entering the
building.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninds.nih.gov, where a agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: December 29, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–142 Filed 1–6–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of meetings of the
National Diabetes and Digestive and
Kidney Diseases Advisory Council.
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
1445
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6). Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commerical
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
Date: February 15–16, 2006.
Open: February 15, 2006, 8:30 a.m. to 12
p.m.
Agenda: To present the Director’s Report
and other scientific presentations.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: February 16, 2006, 9:45 a.m. to
10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Open: February 16, 2006, 10:15 a.m. to 12
p.m.
Agenda: Continuation of the Director’s
Report and other scientific presentations.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division of Extramural Activities,
National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, Bethesda, MD 20892. (301) 594–
8843. stanfieldb@extra.niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council, Diabetes, Endocrinology, and
Metabolic Diseases Subcommittee.
Date: February 15–16, 2006.
Open: February 15, 2006, 1 p.m. to 4 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: February 15, 2006, 4 p.m. to 5:30
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: February 16, 2006, 8 a.m. to 8:30
a.m.
E:\FR\FM\09JAN1.SGM
09JAN1
cprice-sewell on PROD1PC66 with NOTICES
1446
Federal Register / Vol. 71, No. 5 / Monday, January 9, 2006 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Open: February 16, 2006, 8:30 a.m. to 9:30
a.m.
Agenda: Continuation of the review of the
Division’s scientific and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division of Extramural Activities,
National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, Bethesda, MD 20892. (301) 594–
8843. stanfieldb@extra.niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council, Digestive Diseases and Nutrition
Subcommittee.
Date: February 15–16, 2006.
Open: February 15, 2006, 1 p.m. to 3 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 9A22, Bethesda, MD 20892.
Closed: February 15, 2006, 3:15 p.m. to
5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 9A22, Bethesda, MD 20892.
Open: February 16, 2006, 8 a.m. to 9:30
a.m.
Agenda: Continuation of the review of the
Division’s scientific and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 9A22, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director of Extramural Activities, National
Institute of Diabetes and Digestive and
Kidney Diseases, 6707 Democracy Blvd.,
Room 715, Bethesda, MD 20892. (301) 594–
8843. stanfieldb@extra.niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council, Kidney, Urologic, and Hematologic
Diseases Subcommittee.
Date: February 15–16, 2006.
Open: February 15, 2006, 1 p.m. to 5:30
p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room, Bethesda, MD 20892.
Closed: February 16, 2006, 8 a.m. to 9:30
a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 7, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division of Extramural Activities,
National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, Bethesda, MD 20892. (301) 594–
8843. stanfieldb@extra.niddk.nih.gov.
Any interested person may file written
comments with the committee by forwarding
VerDate Aug<31>2005
15:31 Jan 06, 2006
Jkt 208001
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
into the building by non-government
employees. Persons without a government
I.D. will need to show a photo I.D. and sign
in at the security desk upon entering the
building.
Information is also available on the
Institute’s/Center’s home page: https://
www.niddk.nih.gov/fund/divisions/DEA/
Council/coundesc.htm., where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: December 29, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–143 Filed 1–6–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
collaboration and cooperation between
the NIH and the surrounding
community; (3) conducts and oversees
studies, projects, and evaluations
designed to address problems,
questions, and issues of community
concern and environmental impact; (4)
ensures that NIH activities affecting the
surrounding community involve
community representation at all levels
of design, review, and implementation;
and (5) ensures effective communication
and collaboration on policy and
programs involving the surrounding
community between the Office of the
Director, NIH, and operating
components of the NIH.
(2) Delete the Office of Community
Liaison (NAP, formerly HNAP) in its
entirety.
Delegations of Authority: All
delegations and redelegations of
authority to officers and employees of
NIH that were in effect immediately
prior to the effective date of this
amendment and are consistent with this
amendment shall continue in effect,
pending further redelegation.
Dated: November 4, 2005.
Elias A. Zerhouni,
Director, National Institutes of Health.
[FR Doc. 06–144 Filed 1–6–06; 8:45 am]
BILLING CODE 4140–01–M
National Institutes of Health
Statement of Organization, Functions,
and Delegations of Authority
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Part N, National Institutes of Health,
of the Statement of Organization,
Functions, and Delegations of Authority
for the Department of Health and
Human Services (HHS) (40 FR 22859,
May 27, 1975, as amended most recently
at 69 FR 64081, November 3, 2004, and
redesignated from Part HN as part N at
60 FR 56606, November 9, 1995), is
amended as set forth below to reflect the
reorganization of the Office of the
Director, NIH, by transferring the Office
of Community Liaison from the Office of
the Director (OD) to the Office of
Communications and Public Liaison,
OD.
Section N–B, Organization and
Functions, under the heading Office of
the Director (NA, formerly HNA), is
amended as follows:
(1) Under the heading Office of
Communications and Public Liaison
(NA8, formerly HNA8) insert the
following:
Office of Community Liaison (NA85,
formerly HNA85). (1) Advises the NIH
Director on policies, programs, and
issues involving the NIH and the
surrounding community; (2) plans and
directs activities to promote
National Institutes of Health
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Statement of Organization, Functions,
and Delegations of Authority
Part N, National Institutes of Health,
of the Statement of Organization,
Functions, and Delegations of Authority
for the Department of Health and
Human Services (HHS) (40 FR 22859,
May 27, 1975, as amended most recently
at 70 FR 61146, October 20, 2005, and
redesignated from Part HN as Part N at
60 FR 56606, November 9, 1995), is
amended as set forth below to reflect the
reorganization of the NIH Ethics Office.
Section N-B, Organization and
Functions, under the heading Office of
the Director (NA, formerly HNA), is
amended as follows:
Replace the current section NAT
(formerly HNAT) with the following:
NIH Ethics Office (NAT, formerly
HNAT). (1) Provides oversight and
strategic direction of NIH activities
relating to ethics policy, oversight, and
operational activities; (2) develops and
administers the NIH policies and
procedures for implementing the
Government-wide conflict of interest
statutes and regulations, the HHS
E:\FR\FM\09JAN1.SGM
09JAN1
]]>Agencies
[Federal Register Volume 71, Number 5 (Monday, January 9, 2006)]
[Notices]
[Pages 1445-1446]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-143]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of meetings of
the National Diabetes and Digestive and Kidney Diseases Advisory
Council.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6). Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commerical property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council.
Date: February 15-16, 2006.
Open: February 15, 2006, 8:30 a.m. to 12 p.m.
Agenda: To present the Director's Report and other scientific
presentations.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Closed: February 16, 2006, 9:45 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Open: February 16, 2006, 10:15 a.m. to 12 p.m.
Agenda: Continuation of the Director's Report and other
scientific presentations.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD, Director, Division of
Extramural Activities, National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd., Room 715, Bethesda, MD
20892. (301) 594-8843. stanfieldb@extra.niddk.nih.gov.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council, Diabetes, Endocrinology, and Metabolic
Diseases Subcommittee.
Date: February 15-16, 2006.
Open: February 15, 2006, 1 p.m. to 4 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Closed: February 15, 2006, 4 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Closed: February 16, 2006, 8 a.m. to 8:30 a.m.
[[Page 1446]]
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Open: February 16, 2006, 8:30 a.m. to 9:30 a.m.
Agenda: Continuation of the review of the Division's scientific
and planning activities.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD, Director, Division of
Extramural Activities, National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd., Room 715, Bethesda, MD
20892. (301) 594-8843. stanfieldb@extra.niddk.nih.gov.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council, Digestive Diseases and Nutrition
Subcommittee.
Date: February 15-16, 2006.
Open: February 15, 2006, 1 p.m. to 3 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 9A22, Bethesda, MD 20892.
Closed: February 15, 2006, 3:15 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 9A22, Bethesda, MD 20892.
Open: February 16, 2006, 8 a.m. to 9:30 a.m.
Agenda: Continuation of the review of the Division's scientific
and planning activities.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 9A22, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD, Director of Extramural
Activities, National Institute of Diabetes and Digestive and Kidney
Diseases, 6707 Democracy Blvd., Room 715, Bethesda, MD 20892. (301)
594-8843. stanfieldb@extra.niddk.nih.gov.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council, Kidney, Urologic, and Hematologic
Diseases Subcommittee.
Date: February 15-16, 2006.
Open: February 15, 2006, 1 p.m. to 5:30 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room, Bethesda, MD 20892.
Closed: February 16, 2006, 8 a.m. to 9:30 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 7, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD, Director, Division of
Extramural Activities, National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd., Room 715, Bethesda, MD
20892. (301) 594-8843. stanfieldb@extra.niddk.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance into the building by non-government
employees. Persons without a government I.D. will need to show a
photo I.D. and sign in at the security desk upon entering the
building.
Information is also available on the Institute's/Center's home
page: https://www.niddk.nih.gov/fund/divisions/DEA/Council/
coundesc.htm., where an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: December 29, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-143 Filed 1-6-06; 8:45 am]
BILLING CODE 4140-01-M
